New IV drug aims to ease debilitating CRPS pain in major trial
Symptom relief
Recruiting now
This phase 3 study tests an intravenous drug called AMBTX-01 (neridronate) for people with Complex Regional Pain Syndrome Type 1, a condition causing severe, long-lasting pain in one limb. About 270 adults will receive either the drug or a placebo to see if it safely reduces pain…
Phase: PHASE3 • Sponsor: Ambros Therapeutics, Inc. • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC